Jun 18, 2026 09:20AM
Jun 18, 2026 09:20AM
Jun 9, 2026 09:20AM
Jun 9, 2026 09:20AM
Jun 4, 2026 09:15AM
May 20, 2026 04:06PM
May 20, 2026 04:05PM Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
May 13, 2026 04:05PM
May 11, 2026 09:10AM
May 11, 2026 09:10AM
May 8, 2026 04:05PM
May 8, 2026 04:05PM
May 5, 2026 04:15PM
Apr 8, 2026 09:15AM Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
Mar 17, 2026 04:05PM
Mar 12, 2026 09:00AM
Mar 11, 2026 04:05PM
Mar 11, 2026 04:05PM
Mar 10, 2026 09:01AM
Mar 10, 2026 09:00AM
Feb 25, 2026 11:05AM Longeveron publishes Phase 2b stem cell trial results in Cell Stem Cell
Feb 25, 2026 11:05AM
Feb 13, 2026 04:30PM
Feb 13, 2026 04:30PM
Feb 5, 2026 09:15AM
Jan 29, 2026 09:15AM
Jan 29, 2026 09:15AM
Jan 26, 2026 09:15AM Longeveron gets FDA Type C meeting for rare heart condition trial
Jan 26, 2026 09:15AM
Dec 29, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 3, 2025 09:15AM
Dec 3, 2025 09:15AM
Dec 2, 2025 09:15AM Longeveron receives Canadian patent for stem cell treatments
Dec 2, 2025 09:15AM
Dec 1, 2025 12:02PM
Dec 1, 2025 12:00PM
Nov 19, 2025 09:15AM
Nov 19, 2025 09:15AM
Nov 12, 2025 09:05AM
Nov 12, 2025 09:05AM Longeveron Granted U.S. Patent for Method of Treating Aging-related Frailty in Patients with Inflammaging Using its Proprietary Stem Cell Therapy
Nov 4, 2025 04:05PM
Oct 28, 2025 09:15AM
Oct 27, 2025 09:15AM
Oct 6, 2025 09:15AM
Oct 1, 2025 04:05PM
Oct 1, 2025 04:05PM
Sep 22, 2025 09:15AM Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
Sep 3, 2025 04:05PM

323,580 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All